CARE-FOR-RARE FOUNDATION
LIVE

Serial Number

97174137

Owner

Prof. Dr. jur. Andreas Staudacher

Attorney

Mark J. Liss

First Use Date

Jul 10, 2023

Filing Date

Dec 15, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CARE-FOR-RARE FOUNDATION Trademark

Serial Number: 97174137 • Registration: 7392324

CARE-FOR-RARE FOUNDATION is a trademark filed by Prof. Dr. jur. Andreas Staudacher on December 15, 2021. The trademark is classified under Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Prof. Dr. jur. Andreas Staudacher (3 trademarks)

Berblingerstraße 31
Laupheim 88471 , DE

Entity Type: 01

Prof. Dr. Dr. Christoph Klein (3 trademarks)

Elmauer Str. 2a

Entity Type: 01

Trademark Details

Filing Date

December 15, 2021

Registration Date

May 21, 2024

First Use Anywhere

July 10, 2023

First Use in Commerce

July 10, 2023

Published for Opposition

August 15, 2023

Goods & Services

Education services, namely, providing modes of instruction in the fields of medical science, natural science, data science, analyzing educational test scores and data for others, providing educational testing, providing supervision during an educational fellowship; training services, namely, workshops, seminars, internships, conferences in the fields of medical science, natural science, data science; consulting in the fields of medical and scientific research; providing online non-downloadable electronic publications in the nature of books, magazines, brochures, articles in scientific publications in the field of education and research; education services, namely, instruction via classes, workshops, seminars in the field of medical research, in particular, relating to rare diseases and precision medicine; organization and conducting of training in the field of medical research and care of rare pediatric diseases; organizing and conducting colloquia, symposia, seminars and workshops in the field of medical and scientific research relating to precision medicine and rare diseases; conducting live and evening events, namely, scientific conferences, symposia, workshops, seminars and congresses in the field of precautionary education on the awareness and prevention of rare diseases and precision medicine; publishing books; online electronic publishing of books and magazines, publishing texts in the nature of books, magazines, newsletters, articles in scientific publications, except for promotional purposes; organizing and conducting charity events and campaigns in the nature of seminars and congresses in the field of precautionary education on the awareness and prevention of rare diseases and precision medicine, photo exhibitions, award-ceremonies, the proceeds of which are donated to charity; publishing printed books, magazines, newsletters, articles and contributions in scientific publications in electronic form, namely, on the Internet, except for promotional purposes, in the fields of rare diseases of humans, in particular of children, namely, genetic disorders of the blood and the immune system, congenital neutropenia, congenital disorders of the immune system and inflammatory bowel diseases; conducting trainings, seminars and congresses in the field of precautionary education on the awareness and prevention of rare diseases and precision medicine; education services, namely, classes, workshops, seminars, scientific conferences in the field of medicine

Money transactions services, namely, electronic transfers of money, money ordering services related to the collection of monetary donations; collecting monetary donations as charitable fundraising services for charitable and benevolent purposes; financing the education of clinician scientists, namely, financing research fellowships, continuous education programs, and conference participation in the field of medical science; financing research in the fields of medical science, natural science, and data science

Medical services, namely, clinical and diagnostic analysis and therapy development, in particular, pharmacotherapy and cell and gene therapy; ambulatory and mobility care services, namely, the provision of medical and therapeutic care in the fields of rare human diseases, in particular of children, namely, genetic diseases, diseases of the blood and immune system, congenital neutropenia, congenital disorder of the immune system and inflammatory bowel disease; clinical, immunological, molecular biological, biochemical, chemical and genetic diagnostics being medical testing for diagnostic or treatment purposes; providing medical information; medical care services in the nature of psychosocial care; medical therapeutic counseling

scientific and biological research services; technological research services in the field of rare diseases and precision medicine; conducting clinical, diagnostic, chemical, Scientific and biological research services; technological research services in the field of rare diseases and precision medicine; conducting clinical, diagnostic, Scientific and biological research services; technological research services in the field of rare diseases and precision medicine; conducting clinical, diagnostic, chemical, biological, genetic, molecular and biotechnological analyses for optimization of diagnosis, therapy and prevention of severe diseases; conducting clinical, immunological and genetic diagnostics testing and drug development; conducting scientific investigations for severe and life-threatening diseases for medical purposes; preparing scientific reports for medical and scientific research purposes; scientific research, biological, chemical and medical research; development of new medical therapies, namely, pharmacotherapy and cell and gene therapy; medical research and therapy development services in the field of rare human diseases, in particular of children, namely, genetic diseases, blood and immune system disorders, congenital neutropenia and inflammatory bowel diseases; consulting in the fields of medical and scientific research

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
May 6, 2025 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Apr 17, 2025 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2025 APRE
TEAS SECTION 7 REQUEST RECEIVED
Nov 11, 2024 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 21, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
May 21, 2024 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 16, 2024 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 15, 2024 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Apr 12, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 12, 2024 AITU
USE AMENDMENT FILED
Mar 22, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Mar 22, 2024 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 10, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2023 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 11, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Jul 11, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 11, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Jul 11, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jul 11, 2023 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 14, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 13, 2023 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jun 13, 2023 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Apr 18, 2023 GNFN
FINAL REFUSAL E-MAILED
Apr 18, 2023 GNFR
FINAL REFUSAL WRITTEN
Apr 18, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 9, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 9, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 22, 2022 GNRN
NON-FINAL ACTION E-MAILED
Sep 22, 2022 GNRT
NON-FINAL ACTION WRITTEN
Sep 22, 2022 CNRT
ASSIGNED TO EXAMINER
Sep 21, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Dec 21, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2021 NWOS
NEW APPLICATION ENTERED
Dec 18, 2021 NWAP